Despite the Trump administration sentiment that the U.S. partner with Saudi Arabia in a joint oil alliance, such an approach is unlikely to be successful, write energy fellows Jim Krane and Mark Finley. Forbes blog: https://bit.ly/2WUa6rb
"With the U.S. and Iran staggering toward war, it bears asking: How would U.S. interests be served by war with Iran?" writes fellow Jim Krane. Read his argument for why U.S. interests would be deeply undermined by any such war on the Baker Institute Blog.
This post originally appeared in the Forbes Blog on June 17, 2019.
Days after the attacks on the World Trade Center, William Martin, the Harry and Hazel Chavanne Senior Fellow in Religion and Public Policy and Chavanne Emeritus Professor in Rice’s Department of Sociology, spoke to a gathering of Rice University students, faculty and staff. These are his remarks.
Saudi Arabia recently ended its legal ban on women driving. The long-term consequences of this change on transportation, energy, labor, and health remain unclear, write fellows Farhan Majid and Jim Krane in an op-ed for the Houston Chronicle: https://bit.ly/2Lrqnja
The Texas House of Representatives is considering House Bill 3256, which would legalize syringe exchange programs (SEPs) as a means of reducing the transmission of infectious and communicable diseases among people who inject drugs. On April 25, William Martin, director of the Drug Policy Program, appeared before the Texas House Committee on Public Health to testify in support of HB 3256. Martin also authored an op-ed in TribTalk supporting the establishment of SEPs.
Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”
Katharine Neill Harris, William MartinDecember 19, 2014
In this installment of Baker Institute Viewpoints, experts discuss the question, "What does jury nullification of marijuana cases in Texas indicate about the possibility of marijuana legalization?"